ÂÜÀòÂÒÂ×

Hernando C. Giraldo is an accomplished professional in digital innovation and clinical trials, currently serving as Associate Director of Digital Innovation & OmniChannel Engagement at Eisai US. Prior experience includes key roles at Boehringer Ingelheim, such as leading the Digital Lab, acting as Global Head of the Digital Trials Team, and serving as US Regional Lead for Digital Development and Operations. Hernando has held leadership positions in external initiatives, including Team Lead for Blockchain in Trial Conduct at PharmaLedger and as a Steering Committee Member for the Clinical Trials Transformation Initiative. Academic qualifications include coursework in a Master's in Innovation and Corporate Entrepreneurship from Penn State University and a Bachelor of Science in Business Administration from Centenary University.